机器人臂辅助18F-FDG PET/CT引导活检在不明原因发热患者中的应用:单中心经验
本研究回顾性分析165例不明原因发热(FUO)患者,评估机器人臂辅助18F-FDG PET/CT引导靶向活检的诊断效能与安全性。结果显示诊断率为96.4%,最常见病因为恶性肿瘤(42%),其次为感染(35%),仅3.6%出现操作相关并发症。该方法对FDG高摄取可及病灶安全准确,有助于早期诊断与管理。
要点
- FUO患者PET/CT引导活检诊断率高达96.4%,恶性肿瘤占42%。
- 靶病灶中位SUVmax为11.8,不同病因间无显著差异(p=0.412)。
- 操作相关并发症仅3.6%,安全性良好。
核心结论
- 机器人臂辅助18F-FDG PET/CT引导活检对FDG高摄取可及病灶的FUO患者安全准确,可能有助于早期诊断和管理。
研究设计与样本
- 单中心回顾性研究纳入2017年至2025年6月间接受18F-FDG PET/CT引导活检的165例FUO患者,中位年龄47岁(IQR 30-60)。
- 以组织病理学检查为参考标准,计算诊断率并记录操作相关并发症。
主要发现
- 165例中64例(39%)曾接受过既往操作但结果阴性或不确定。
- 最常见靶活检部位为肺部(71/165,43%)。
- 诊断率为96.4%(159/165),最常见病因为恶性肿瘤(70/165,42%),其次为感染(58/165,35%)、自身免疫(16/165,10%)和炎症(7/165,4%)。
- 靶病灶中位SUVmax为11.8(IQR 8.6-16.3;范围3.3-53.8),不同病因靶病灶间无显著差异(p=0.412)。
- 仅6例(3.6%)出现操作相关并发症。
临床怎么用
- 对FUO患者且存在FDG高摄取可及病灶时,可考虑机器人臂辅助PET/CT引导靶向活检以获取病理诊断。
局限性
- 单中心回顾性设计可能限制结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Fever of unknown origin (FUO) is a prolonged fever with unknown etiology after an extensive outpatient or inpatient workup. 18F-Flurodeoxyglucose (FDG) positron emission tomography (PET) with computed tomography (CT) has shown a higher diagnostic yield than CT. This study assesses the diagnostic yield of 18F-FDG PET/CT-guided targeted biopsy in FUO. METHODS: This single-centre retrospective study included FUO patients who underwent 18F-FDG PET/CT-guided biopsy. A distinct focal area of FDG-uptake above the surrounding background within the organ of interest was considered PET-positive and targeted using automated robotic arm-assisted PET/CT-guided biopsy systems. Procedure-related complications were recorded, and histopathological examination was taken as the reference standard. Diagnostic yield and other PET-based parameters were calculated. RESULTS: Data from 165 FUO patients [median age 47 years (IQR, 30-60)] who underwent 18F-FDG PET/CT-guided biopsy between 2017 and June 2025 were analysed. 64 (39%) had undergone a previous procedure with negative or inconclusive results. The most common site of targeted biopsy was the lungs (71/165, 43%). The diagnostic yield of 18F-FDG PET/CT-guided biopsy in FUO patients was 96.4% (159/165), with the most common cause being malignancy (70/165, 42%), followed by infection (58/165, 35%), autoimmune (16/165, 10%) and inflammatory (7/165, 4%) causes. The median SUVmax of the target lesions was 11.8 (IQR, 8.6-16.3; range, 3.3-53.8) with no significant difference among target lesions of different etiologies (p = 0.412). Only six patients (3.6%) had procedure-related complications. CONCLUSION: Robotic arm-assisted 18F-FDG PET/CT-guided biopsy is a safe and accurate procedure in FUO patients having FDG-avid accessible lesions and may help in early diagnosis and management.
引用
- Aggarwal P, Singh H, Kumar R, et al. Robotic arm-assisted 18F-FDG PET/CT-guided biopsy in febrile patients with biopsy accessible FDG-avid lesions: a single-centre experience. Eur J Nucl Med Mol Imaging. 2026. PMID: 42144417. doi:10.1007/s00259-026-07928-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。